Free Trial

Delek US (DK) Financials

Delek US logo
$19.77 +0.35 (+1.80%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$19.78 +0.01 (+0.05%)
As of 07:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Delek US

Annual Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
-560 20 257 -128 -611 311 340 289 -154 19
Consolidated Net Income / (Loss)
-521 47 291 -95 -574 336 375 323 -133 44
Net Income / (Loss) Continuing Operations
-598 20 265 -95 -574 331 384 329 -220 37
Total Pre-Tax Income
-706 17 322 -137 -767 403 486 299 -391 21
Total Operating Income
-492 245 458 -35 -732 492 612 180 -49 69
Total Gross Profit
-43 549 748 251 -261 890 973 432 32 545
Total Revenue
11,852 16,467 19,801 10,648 7,302 9,298 10,233 7,267 4,198 4,782
Operating Revenue
11,852 16,467 19,801 10,648 7,302 9,298 10,233 7,267 4,198 4,782
Total Cost of Revenue
11,895 15,919 19,053 10,398 7,563 8,408 9,260 6,835 4,166 4,237
Operating Cost of Revenue
11,895 15,919 19,053 10,398 7,563 8,408 9,260 6,835 4,166 4,237
Total Operating Expenses
448 304 290 285 471 398 361 251 81 476
Selling, General & Admin Expense
253 272 314 200 235 275 248 176 106 371
Depreciation Expense
25 17 11 25 26 24 38 21 10 106
Other Operating Expenses / (Income)
-52 -2.50 -3.50 83 85 100 75 54 7.10 -0.50
Impairment Charge
244 38 0.00 0.00 126 0.00 0.00 0.00 0.00 -
Other Special Charges / (Income)
-21 -20 -31 -23 0.00 - - - -42 0.00
Total Other Income / (Expense), net
-215 -228 -136 -103 -35 -90 -126 119 -342 -47
Interest & Investment Income
-221 -232 -138 18 30 46 16 17 -287 3.10
Other Income / (Expense), net
6.30 3.70 2.40 16 60 -4.10 -6.90 196 -0.40 1.60
Income Tax Expense
-108 -3.00 56 -42 -194 72 102 -29 -172 -16
Net Income / (Loss) Discontinued Operations
77 27 25 - - 5.20 -8.70 -5.90 86 6.60
Net Income / (Loss) Attributable to Noncontrolling Interest
40 27 33 33 38 26 35 34 20 24
Basic Earnings per Share
($8.77) $0.30 $3.63 ($1.73) ($8.31) $4.10 $4.11 $4.04 ($2.49) $0.32
Weighted Average Basic Shares Outstanding
63.88M 65.41M 70.79M 73.98M 73.60M 75.85M 82.80M 71.57M 61.92M 60.82M
Diluted Earnings per Share
($8.77) $0.30 $3.59 ($1.73) ($8.31) $4.06 $3.95 $4.00 ($2.49) $0.32
Weighted Average Diluted Shares Outstanding
63.88M 65.41M 71.52M 73.98M 73.60M 76.57M 86.77M 72.30M 61.92M 61.32M
Weighted Average Basic & Diluted Shares Outstanding
62.51M 64.02M 66.94M 74.20M 73.78M 73.41M 78.01M 83.92M - -
Cash Dividends to Common per Share
$1.01 $0.93 $0.61 $0.00 $0.93 $1.14 $0.96 $0.60 $0.60 $0.60

Quarterly Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-173 -414 -77 -37 -33 -165 129 -8.30 64 -119 7.40
Consolidated Net Income / (Loss)
-159 -402 -68 -26 -25 -160 136 -1.50 72 -110 17
Net Income / (Loss) Continuing Operations
-158 -412 -135 -26 -25 -177 126 -1.50 72 -135 17
Total Pre-Tax Income
-195 -465 -175 -34 -32 -221 155 -5.30 88 -186 21
Total Operating Income
-126 -416 -122 14 33 -160 212 50 143 -136 53
Total Gross Profit
-64 -210 -20 57 130 -124 278 158 237 -139 141
Total Revenue
2,642 2,161 3,042 3,422 3,228 3,719 4,629 4,196 3,924 4,034 5,325
Operating Revenue
2,642 2,161 3,042 3,422 3,228 3,719 4,629 4,196 3,924 4,034 5,325
Total Cost of Revenue
2,706 2,370 3,063 3,365 3,098 3,843 4,351 4,038 3,687 4,174 5,184
Operating Cost of Revenue
2,706 2,370 3,063 3,365 3,098 3,843 4,351 4,038 3,687 4,174 5,184
Total Operating Expenses
62 206 102 43 97 36 66 108 94 -3.90 88
Selling, General & Admin Expense
62 55 70 63 64 57 68 76 72 82 59
Depreciation Expense
6.30 -1.00 5.60 11 8.80 -0.70 4.00 6.80 6.60 -6.00 6.40
Other Operating Expenses / (Income)
-5.70 -39 17 -54 24 -38 -5.80 25 16 -49 22
Total Other Income / (Expense), net
-69 -49 -53 -47 -65 -61 -57 -55 -55 -50 -32
Interest & Investment Income
-71 -219 -54 30 22 -217 -55 26 15 -183 18
Other Income / (Expense), net
1.60 5.10 0.50 0.00 0.70 -0.90 -2.00 -0.50 7.10 -0.60 0.70
Income Tax Expense
-37 -53 -40 -7.70 -7.20 -44 29 -3.80 16 -51 4.00
Net Income / (Loss) Discontinued Operations
-0.30 - 67 - - - 11 - - - -
Net Income / (Loss) Attributable to Noncontrolling Interest
14 12 9.30 11 7.40 4.80 7.40 6.80 7.90 9.00 9.40
Basic Earnings per Share
($2.78) ($6.48) ($1.20) ($0.58) ($0.51) ($2.51) $1.98 ($0.13) $0.96 ($1.68) $0.11
Weighted Average Basic Shares Outstanding
62.12M 63.88M 64.06M 64.21M 64.02M 65.41M 64.89M 65.77M 66.95M 70.79M 70.47M
Diluted Earnings per Share
($2.78) ($6.48) ($1.20) ($0.58) ($0.51) ($2.49) $1.97 ($0.13) $0.95 ($1.65) $0.10
Weighted Average Diluted Shares Outstanding
62.12M 63.88M 64.06M 64.21M 64.02M 65.41M 65.46M 65.77M 67.37M 71.52M 71.11M
Weighted Average Basic & Diluted Shares Outstanding
60.73M 62.51M 63.20M 64.54M 64.13M 64.02M 63.93M 64.82M 65.73M 66.94M 69.69M
Cash Dividends to Common per Share
$0.26 - $0.26 $0.25 $0.25 - $0.24 $0.23 $0.22 - $0.40

Annual Cash Flow Statements for Delek US

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-87 -19 -15 69 -168 -124 137 253 387 -142
Net Cash From Operating Activities
-67 1,014 425 371 -283 575 560 320 248 180
Net Cash From Continuing Operating Activities
-84 979 394 371 -283 575 590 322 235 144
Net Income / (Loss) Continuing Operations
-598 20 265 -95 -574 336 375 329 -220 37
Consolidated Net Income / (Loss)
-521 47 291 -95 -574 336 375 323 -133 44
Net Income / (Loss) Discontinued Operations
77 27 25 - - - - -5.90 86 6.60
Depreciation Expense
375 340 275 265 268 194 199 153 116 106
Non-Cash Adjustments To Reconcile Net Income
294 -87 167 284 2.10 101 -85 -24 366 -4.50
Changes in Operating Assets and Liabilities, net
-154 707 -314 -82 21 -56 101 -136 -32 1.30
Net Cash From Discontinued Operating Activities
17 35 32 - - - -30 -2.10 13 36
Net Cash From Investing Activities
-242 -408 -932 -178 -191 -691 -125 38 201 -460
Net Cash From Continuing Investing Activities
-603 -382 -901 -178 -191 -691 -145 25 -88 -435
Purchase of Property, Plant & Equipment
-428 -393 -280 -222 -269 -413 -322 -172 -46 -188
Acquisitions
-205 -4.30 -631 -2.70 -34 -287 -1.90 185 -62 -249
Purchase of Investments
-0.40 -12 0.00 0.00 - - - - - -
Sale of Property, Plant & Equipment
10 1.90 0.20 12 0.20 16 67 0.10 0.20 1.20
Sale and/or Maturity of Investments
5.00 15 9.90 10 72 0.80 1.20 12 20 -
Other Investing Activities, net
14 10 0.00 24 0.00 -8.00 0.00 0.00 - -
Net Cash From Discontinued Investing Activities
362 -26 -30 - - - 20 12 289 -25
Net Cash From Financing Activities
222 -625 491 -124 306 -7.90 -298 -105 -62 139
Net Cash From Continuing Financing Activities
222 -625 491 -124 306 -7.90 -298 -105 -44 91
Repayment of Debt
-8,928 -5,226 -4,831 -2,755 -1,922 -1,590 -2,520 -1,350 -385 -417
Repurchase of Preferred Equity
-71 0.00 0.00 - - - - - - -
Repurchase of Common Equity
-42 -85 -194 0.00 -1.90 -178 -365 -25 -6.00 -42
Payment of Dividends
-64 -60 -79 0.00 -98 -87 -80 -87 -62 -58
Issuance of Debt
7,981 3,546 4,635 1,739 2,068 1,869 2,815 1,408 409 612
Issuance of Common Equity
298 0.00 3.10 0.00 0.00 0.00 - - - -
Other Financing Activities, net
1,047 1,202 956 892 260 -23 -148 -51 -1.10 -2.90
Cash Interest Paid
305 329 189 125 124 126 120 82 52 49
Cash Income Taxes Paid
3.80 11 28 4.20 3.60 94 104 71 1.70 5.10

Quarterly Cash Flow Statements for Delek US

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-112 -302 380 -96 -69 -80 80 -43 24 -313 -91
Net Cash From Operating Activities
-62 -164 -22 -48 167 91 433 95 395 -291 130
Net Cash From Continuing Operating Activities
-62 -163 -39 -48 167 87 402 95 395 -322 130
Net Income / (Loss) Continuing Operations
-158 -401 -146 -26 -25 -163 112 -1.50 72 -135 17
Consolidated Net Income / (Loss)
-159 -402 -68 -26 -25 -160 136 -1.50 72 -110 17
Net Income / (Loss) Discontinued Operations
-0.30 -1.00 - - - 3.20 - - - - -
Depreciation Expense
101 96 91 92 95 84 82 89 83 66 73
Non-Cash Adjustments To Reconcile Net Income
35 270 -76 -2.80 102 -8.00 74 -104 -50 45 -120
Changes in Operating Assets and Liabilities, net
-40 -128 91 -112 -5.60 174 133 111 289 -298 161
Net Cash From Discontinued Operating Activities
-0.30 -0.90 - - - 3.50 - - - - -
Net Cash From Investing Activities
-315 -216 78 -63 -42 -69 -59 -58 -222 -112 -99
Net Cash From Continuing Investing Activities
-315 -216 -283 -63 -42 -61 -41 -58 -222 -82 -99
Purchase of Property, Plant & Equipment
-136 -191 -104 -86 -47 -72 -43 -66 -211 -87 -95
Acquisitions
-186 -25 -178 -0.60 -0.70 -1.70 -1.30 -0.70 -0.60 -1.30 -4.40
Sale of Property, Plant & Equipment
4.30 -0.40 1.10 - - 0.60 0.60 - - -1.00 0.10
Sale and/or Maturity of Investments
2.10 0.90 0.70 0.60 2.80 4.40 3.20 5.20 2.10 8.20 -
Other Investing Activities, net
0.50 -1.30 -2.50 14 3.60 8.80 1.50 4.80 -4.80 - -
Net Cash From Discontinued Investing Activities
0.00 - - - - -8.40 - - - - -
Net Cash From Financing Activities
265 77 323 15 -194 -101 -294 -81 -149 90 -122
Net Cash From Continuing Financing Activities
265 77 323 15 -194 -101 -294 -81 -149 90 -122
Repayment of Debt
-2,554 -2,505 -2,047 -1,832 -2,544 -1,265 -1,564 -1,033 -1,366 -3,065 -380
Repurchase of Common Equity
-32 -22 -20 - 0.00 -20 -25 -40 -0.40 -90 -40
Payment of Dividends
-16 -16 -16 -6.20 -26 -15 3.90 -25 -24 -51 -28
Issuance of Debt
2,820 1,382 2,734 1,723 2,143 930 1,068 698 849 3,064 101
Issuance of Common Equity
0.00 166 - -0.10 132 - - - 0.00 - -
Other Financing Activities, net
46 1,143 -328 131 100 269 222 318 392 228 226
Cash Interest Paid
94 71 88 70 75 97 72 54 106 75 38

Annual Balance Sheets for Delek US

This table presents Delek US's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Total Assets
6,666 7,172 8,193 6,813 6,134 7,016 5,761 5,935 2,980
Total Current Assets
2,332 2,666 3,717 3,020 2,300 2,963 2,420 2,612 1,397
Cash & Equivalents
736 822 841 857 788 955 1,079 932 689
Accounts Receivable
618 784 1,234 777 528 793 514 582 266
Inventories, net
893 941 1,519 1,261 728 947 678 808 392
Other Current Assets
86 78 123 126 256 269 149 130 49
Other Current Nonoperating Assets
0.00 42 - - - - - 160 0.00
Plant, Property, & Equipment, net
2,940 2,696 2,776 2,307 2,367 2,428 2,195 2,141 1,103
Plant, Property & Equipment, gross
4,948 4,460 4,349 3,645 3,520 3,363 3,000 2,773 1,588
Accumulated Depreciation
2,008 1,764 1,573 1,338 1,152 935 805 632 484
Total Noncurrent Assets
1,394 1,810 1,700 1,486 1,467 1,625 1,145 1,183 480
Long-Term Investments
393 361 360 344 364 407 130 138 360
Goodwill
475 688 744 730 730 856 858 817 12
Intangible Assets
322 288 316 103 108 110 104 101 27
Other Noncurrent Operating Assets
204 246 280 309 266 251 53 127 81
Other Noncurrent Nonoperating Assets
0.00 228 - - - - - - -
Total Liabilities & Shareholders' Equity
6,666 7,172 8,193 6,813 6,134 7,016 5,761 5,935 2,980
Total Liabilities
6,091 6,212 7,123 5,799 5,009 5,181 3,953 3,971 1,797
Total Current Liabilities
2,516 2,685 3,086 3,127 1,903 2,356 1,664 2,672 935
Short-Term Debt
9.50 45 75 92 33 36 32 590 84
Accounts Payable
1,814 1,814 1,746 1,695 1,144 1,600 1,011 975 496
Other Current Liabilities
693 815 1,266 1,339 726 720 620 1,001 354
Other Current Nonoperating Liabilities
0.00 12 - - - - - 106 0.00
Total Noncurrent Liabilities
3,575 3,527 4,037 2,672 3,106 2,825 2,289 1,299 862
Long-Term Debt
2,756 2,555 2,979 2,126 2,315 2,031 1,751 875 749
Asset Retirement Reserve & Litigation Obligation
58 147 153 148 145 207 215 141 11
Noncurrent Deferred & Payable Income Tax Liabilities
215 264 267 215 256 268 210 200 76
Other Noncurrent Operating Liabilities
546 526 638 184 390 320 113 83 26
Other Noncurrent Nonoperating Liabilities
0.00 34 - - - - - - -
Total Equity & Noncontrolling Interests
575 960 1,070 1,014 1,125 1,835 1,808 1,964 1,183
Total Preferred & Common Equity
313 846 944 894 1,007 1,666 1,633 1,651 992
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
313 846 944 894 1,007 1,666 1,633 1,651 992
Common Stock
1,217 1,114 1,135 1,207 1,186 1,153 1,136 901 651
Retained Earnings
-206 430 508 385 522 1,206 982 768 522
Treasury Stock
-694 -694 -694 -694 -694 -692 -514 -25 -161
Accumulated Other Comprehensive Income / (Loss)
-4.10 -4.80 -5.20 -3.80 -7.20 0.10 29 6.90 -21
Noncontrolling Interest
262 114 126 120 118 169 176 314 191

Quarterly Balance Sheets for Delek US

This table presents Delek US's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
6,882 7,030 6,944 7,180 7,869 7,770 7,787 8,397
Total Current Assets
2,215 2,565 2,501 2,708 3,333 3,196 3,187 4,030
Cash & Equivalents
624 1,038 658 753 902 822 865 1,154
Accounts Receivable
649 562 771 832 1,167 1,004 848 1,036
Inventories, net
853 915 1,010 1,038 1,179 1,276 1,315 1,634
Other Current Assets
90 51 61 85 86 95 159 206
Plant, Property, & Equipment, net
3,187 2,829 2,786 2,804 2,835 2,869 2,882 2,678
Plant, Property & Equipment, gross
5,284 4,791 4,799 4,736 4,603 4,577 4,529 4,192
Accumulated Depreciation
2,097 1,962 2,014 1,932 1,768 1,708 1,647 1,514
Total Noncurrent Assets
1,480 1,637 1,657 1,668 1,701 1,704 1,718 1,689
Long-Term Investments
397 409 387 370 371 364 354 361
Goodwill
475 688 729 729 744 744 744 744
Intangible Assets
403 329 284 291 300 305 310 321
Other Noncurrent Operating Assets
205 212 256 277 285 291 309 264
Total Liabilities & Shareholders' Equity
6,882 7,030 6,944 7,180 7,869 7,770 7,787 8,397
Total Liabilities
6,453 6,085 5,961 6,145 6,712 6,707 6,662 7,114
Total Current Liabilities
2,592 2,467 2,565 2,607 3,003 2,915 2,870 3,829
Short-Term Debt
9.50 9.50 9.50 15 30 50 50 63
Accounts Payable
1,834 1,714 1,861 1,732 2,007 1,990 1,794 2,150
Other Current Liabilities
749 744 694 860 966 875 1,026 1,616
Total Noncurrent Liabilities
3,861 3,618 3,396 3,539 3,709 3,792 3,793 3,285
Long-Term Debt
3,026 2,780 2,452 2,482 2,609 2,761 2,726 2,671
Asset Retirement Reserve & Litigation Obligation
65 58 59 154 155 154 154 153
Noncurrent Deferred & Payable Income Tax Liabilities
191 244 262 270 304 281 284 310
Other Noncurrent Operating Liabilities
579 536 623 633 642 596 630 151
Total Equity & Noncontrolling Interests
429 875 983 1,035 1,157 1,063 1,124 1,283
Total Preferred & Common Equity
155 703 806 855 1,038 941 1,000 1,160
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
155 703 806 855 1,038 941 1,000 1,160
Common Stock
1,249 1,174 1,177 1,173 1,117 1,123 1,142 1,127
Retained Earnings
-395 229 328 382 620 518 557 732
Treasury Stock
-694 -694 -694 -694 -694 -694 -694 -694
Accumulated Other Comprehensive Income / (Loss)
-4.10 -4.80 -4.80 -4.80 -5.30 -5.30 -5.20 -4.00
Noncontrolling Interest
274 172 177 180 119 122 124 123

Annual Metrics And Ratios for Delek US

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-28.03% -16.84% 85.96% 45.83% -21.47% -9.14% 40.81% 73.11% -12.21% 0.00%
EBITDA Growth
-118.83% -20.00% 199.10% 160.76% -159.25% -15.15% 51.83% 651.49% -60.92% 0.00%
EBIT Growth
-295.33% -45.99% 2,533.33% 97.19% -237.65% -19.31% 60.69% 859.07% -170.55% 0.00%
NOPAT Growth
-219.08% -23.43% 1,653.38% 95.26% -226.68% -16.30% 144.31% 674.59% -128.78% 0.00%
Net Income Growth
-1,215.42% -83.92% 404.83% 83.39% -270.67% -10.32% 16.21% 341.83% -405.26% 0.00%
EPS Growth
-3,023.33% -91.64% 307.51% 79.18% -304.68% 2.78% -1.25% 260.64% -878.13% 0.00%
Operating Cash Flow Growth
-106.59% 138.33% 14.51% 231.28% -149.18% 2.66% 75.26% 28.91% 37.78% 0.00%
Free Cash Flow Firm Growth
-138.07% 306.03% -292.53% 190.35% -219.69% -39.47% 135.69% -14.10% 0.00% 0.00%
Invested Capital Growth
2.73% -26.32% 43.85% -12.53% -8.56% 6.63% 3.30% 138.65% 0.00% 0.00%
Revenue Q/Q Growth
-14.49% -4.42% 4.91% 13.01% -5.21% -2.01% -0.09% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-163.51% -7.94% -18.25% 422.44% -397.42% -17.05% 10.16% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
-142.24% -18.72% -25.92% 94.78% -119.39% -21.65% 12.89% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
-144.77% -6.94% -22.80% 90.82% -100.25% -18.29% -23.36% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
-86.77% -51.91% -26.47% 74.83% -131.93% -21.01% -20.67% 0.00% 0.00% 0.00%
EPS Q/Q Growth
-83.47% -73.68% -29.19% 68.94% -117.54% -20.39% -29.08% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-135.63% 60.38% -51.52% 13.54% -3.63% -28.77% 24.93% 60.73% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
-532.88% 264.09% -38,575.05% -38.52% 37.53% -52.32% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-3.35% -14.63% 16.79% 0.82% -14.41% 1.73% -5.44% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
-0.36% 3.33% 3.78% 2.35% -3.57% 9.57% 9.51% 5.94% 0.76% 11.40%
EBITDA Margin
-0.93% 3.57% 3.71% 2.31% -5.54% 7.34% 7.86% 7.29% 1.68% 3.77%
Operating Margin
-4.15% 1.49% 2.31% -0.33% -10.03% 5.29% 5.98% 2.48% -1.17% 1.44%
EBIT Margin
-4.09% 1.51% 2.32% -0.18% -9.20% 5.25% 5.91% 5.18% -1.18% 1.47%
Profit (Net Income) Margin
-4.40% 0.28% 1.47% -0.90% -7.86% 3.62% 3.66% 4.44% -3.18% 0.91%
Tax Burden Percent
73.78% 281.33% 90.27% 69.41% 74.77% 83.49% 77.22% 107.78% 34.10% 205.16%
Interest Burden Percent
145.51% 6.68% 69.97% 726.46% 114.20% 82.49% 80.25% 79.50% 788.71% 30.30%
Effective Tax Rate
0.00% -18.07% 17.53% 0.00% 0.00% 17.80% 20.99% -9.76% 0.00% -74.18%
Return on Invested Capital (ROIC)
-15.76% 11.39% 15.23% -1.12% -21.09% 16.44% 20.63% 12.10% -7.13% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-28.26% -4.52% 9.18% -7.53% -27.52% 5.73% -3.10% 211.15% 84.37% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-52.11% -6.78% 12.65% -7.79% -17.68% 2.01% -0.75% 8.41% -15.43% 0.00%
Return on Equity (ROE)
-67.87% 4.60% 27.89% -8.91% -38.77% 18.46% 19.88% 20.50% -22.56% 0.00%
Cash Return on Invested Capital (CROIC)
-18.45% 41.69% -20.73% 12.25% -12.14% 10.02% 17.39% -69.79% -207.13% 0.00%
Operating Return on Assets (OROA)
-7.01% 3.23% 6.13% -0.29% -10.22% 7.64% 10.35% 8.45% -1.66% 0.00%
Return on Assets (ROA)
-7.53% 0.61% 3.87% -1.47% -8.73% 5.26% 6.41% 7.24% -4.48% 0.00%
Return on Common Equity (ROCE)
-51.22% 4.06% 24.60% -7.92% -35.00% 16.71% 17.30% 17.22% -18.93% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-166.53% 5.52% 30.79% -10.66% -57.00% 20.18% 22.96% 19.54% -13.45% 0.00%
Net Operating Profit after Tax (NOPAT)
-344 289 377 -24 -513 405 483 198 -34 120
NOPAT Margin
-2.90% 1.75% 1.91% -0.23% -7.02% 4.35% 4.72% 2.72% -0.82% 2.50%
Net Nonoperating Expense Percent (NNEP)
12.50% 15.90% 6.05% 6.41% 6.44% 10.71% 23.72% -199.06% -91.50% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-10.30% 8.12% 9.15% - - - - - - -
Cost of Revenue to Revenue
100.36% 96.67% 96.22% 97.65% 103.57% 90.43% 90.49% 94.06% 99.24% 88.60%
SG&A Expenses to Revenue
2.13% 1.65% 1.58% 1.88% 3.21% 2.95% 2.42% 2.42% 2.53% 7.76%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
3.78% 1.84% 1.47% 2.68% 6.45% 4.28% 3.53% 3.46% 1.93% 9.96%
Earnings before Interest and Taxes (EBIT)
-485 248 460 -19 -672 488 605 377 -50 70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-111 588 735 246 -404 683 804 530 71 180
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.74 1.86 1.84 1.14 1.08 1.30 1.37 1.42 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 16.42 6.40 3.09 3.34 3.19 0.00 0.00
Price to Revenue (P/Rev)
0.10 0.10 0.09 0.10 0.15 0.23 0.22 0.32 0.00 0.00
Price to Earnings (P/E)
0.00 79.62 6.74 0.00 0.00 6.96 6.58 8.10 0.00 0.00
Dividend Yield
5.43% 3.75% 2.45% 0.00% 8.38% 3.92% 3.52% 2.09% 3.11% 3.68%
Earnings Yield
0.00% 1.26% 14.84% 0.00% 0.00% 14.38% 15.20% 12.35% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.39 1.44 1.27 1.06 1.03 1.19 1.25 1.32 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.26 0.19 0.19 0.20 0.33 0.33 0.29 0.42 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 5.29 5.05 8.76 0.00 4.45 3.71 5.75 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 12.51 8.07 0.00 0.00 6.21 4.94 8.10 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 10.76 9.83 0.00 0.00 7.50 6.18 15.40 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 3.07 8.73 5.80 0.00 5.27 5.33 9.53 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 2.94 0.00 8.07 0.00 12.30 7.33 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
4.81 2.71 2.86 2.19 2.09 1.13 0.99 0.75 0.70 0.00
Long-Term Debt to Equity
4.79 2.66 2.79 2.10 2.06 1.11 0.97 0.45 0.63 0.00
Financial Leverage
1.84 1.50 1.38 1.04 0.64 0.35 0.24 0.04 -0.18 0.00
Leverage Ratio
9.02 7.57 7.20 6.05 4.44 3.51 3.10 2.83 2.52 0.00
Compound Leverage Factor
13.12 0.51 5.04 43.97 5.07 2.89 2.49 2.25 19.87 0.00
Debt to Total Capital
82.78% 73.04% 74.06% 68.63% 67.61% 52.97% 49.65% 42.73% 41.33% 0.00%
Short-Term Debt to Total Capital
0.28% 1.25% 1.81% 2.85% 0.96% 0.93% 0.89% 17.21% 4.19% 0.00%
Long-Term Debt to Total Capital
82.50% 71.79% 72.25% 65.77% 66.65% 52.04% 48.76% 25.52% 37.14% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
7.86% 3.21% 3.05% 3.71% 3.41% 4.33% 4.89% 9.14% 9.46% 0.00%
Common Equity to Total Capital
9.36% 23.75% 22.89% 27.67% 28.98% 42.70% 45.46% 48.13% 49.22% 0.00%
Debt to EBITDA
-24.98 4.42 4.16 9.03 -5.81 3.03 2.22 2.77 11.81 0.00
Net Debt to EBITDA
-14.79 2.41 2.52 4.14 -2.96 1.03 0.71 0.75 -3.07 0.00
Long-Term Debt to EBITDA
-24.89 4.35 4.05 8.65 -5.72 2.98 2.18 1.65 10.62 0.00
Debt to NOPAT
-8.04 9.00 8.09 -91.31 -4.58 5.11 3.69 7.41 -24.18 0.00
Net Debt to NOPAT
-4.76 4.91 4.91 -41.89 -2.34 1.74 1.19 2.00 6.28 0.00
Long-Term Debt to NOPAT
-8.01 8.84 7.90 -87.52 -4.52 5.02 3.62 4.42 -21.73 0.00
Altman Z-Score
1.58 2.64 2.93 1.72 1.16 2.15 2.86 1.96 0.00 0.00
Noncontrolling Interest Sharing Ratio
24.54% 11.83% 11.79% 11.14% 9.71% 9.46% 12.97% 16.02% 16.12% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.93 0.99 1.20 0.97 1.21 1.26 1.45 0.98 1.49 0.00
Quick Ratio
0.54 0.60 0.67 0.52 0.69 0.74 0.96 0.57 1.02 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-403 1,058 -513 267 -295 247 407 -1,142 -1,001 0.00
Operating Cash Flow to CapEx
-16.00% 259.50% 151.89% 176.60% -105.09% 144.96% 219.38% 185.98% 537.96% 96.51%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 1.95 -2.35 1.88 3.02 -12.17 -18.39 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 2.72 -2.25 4.39 4.15 3.41 4.56 3.45
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 1.18 -4.39 1.36 2.26 1.58 3.71 -0.12
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.71 2.14 2.64 1.64 1.11 1.46 1.75 1.63 1.41 0.00
Accounts Receivable Turnover
16.92 16.32 19.69 16.33 11.06 14.23 18.67 17.15 15.78 0.00
Inventory Turnover
12.97 12.94 13.71 10.46 9.03 10.35 12.46 11.38 10.62 0.00
Fixed Asset Turnover
4.21 6.02 7.79 4.56 3.05 4.02 4.72 4.48 3.80 0.00
Accounts Payable Turnover
6.56 8.94 11.07 7.32 5.51 6.44 9.32 9.29 8.39 0.00
Days Sales Outstanding (DSO)
21.58 22.37 18.53 22.36 33.00 25.65 19.55 21.29 23.13 0.00
Days Inventory Outstanding (DIO)
28.14 28.20 26.62 34.90 40.41 35.26 29.29 32.06 34.38 0.00
Days Payable Outstanding (DPO)
55.66 40.81 32.96 49.84 66.21 56.67 39.15 39.29 43.49 0.00
Cash Conversion Cycle (CCC)
-5.94 9.75 12.20 7.42 7.20 4.25 9.69 14.06 14.02 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
2,212 2,153 2,922 2,031 2,322 2,540 2,382 2,306 966 0.00
Invested Capital Turnover
5.43 6.49 7.99 4.89 3.00 3.78 4.37 4.44 8.69 0.00
Increase / (Decrease) in Invested Capital
59 -769 891 -291 -217 158 76 1,340 966 0.00
Enterprise Value (EV)
3,068 3,108 3,711 2,152 2,398 3,034 2,987 3,048 0.00 0.00
Market Capitalization
1,169 1,577 1,732 1,015 1,082 2,160 2,238 2,339 0.00 0.00
Book Value per Share
$4.95 $13.22 $13.54 $12.06 $13.65 $22.45 $19.92 $20.26 $16.02 $0.00
Tangible Book Value per Share
($7.66) ($2.03) ($1.67) $0.83 $2.30 $9.43 $8.18 $9.00 $15.39 $0.00
Total Capital
3,340 3,560 4,123 3,232 3,474 3,902 3,591 3,430 2,015 0.00
Total Debt
2,765 2,600 3,054 2,218 2,348 2,067 1,783 1,466 833 0.00
Total Long-Term Debt
2,756 2,555 2,979 2,126 2,315 2,031 1,751 875 749 0.00
Net Debt
1,637 1,417 1,853 1,017 1,197 705 574 396 -216 0.00
Capital Expenditures (CapEx)
418 391 280 210 269 397 255 172 46 187
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-910 -796 -136 -871 -358 -312 -291 -402 -143 0.00
Debt-free Net Working Capital (DFNWC)
-175 25 705 -15 430 644 789 530 546 0.00
Net Working Capital (NWC)
-184 -19 631 -107 396 607 757 -60 462 0.00
Net Nonoperating Expense (NNE)
177 242 87 71 61 68 109 -125 99 76
Net Nonoperating Obligations (NNO)
1,637 1,194 1,853 1,017 1,197 705 574 342 -216 0.00
Total Depreciation and Amortization (D&A)
375 340 275 265 268 194 199 153 120 110
Debt-free, Cash-free Net Working Capital to Revenue
-7.68% -4.84% -0.69% -8.18% -4.90% -3.35% -2.84% -5.52% -3.41% 0.00%
Debt-free Net Working Capital to Revenue
-1.47% 0.15% 3.56% -0.14% 5.88% 6.92% 7.71% 7.30% 13.01% 0.00%
Net Working Capital to Revenue
-1.55% -0.12% 3.18% -1.00% 5.43% 6.53% 7.40% -0.82% 11.00% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($8.77) $0.30 $3.63 ($2.75) ($8.26) $4.10 $0.00 $4.04 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
63.88M 65.41M 70.79M 73.98M 73.60M 75.85M 0.00 71.57M 0.00 0.00
Adjusted Diluted Earnings per Share
($8.77) $0.30 $3.59 ($2.75) ($8.26) $4.06 $0.00 $4.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
63.88M 65.98M 71.52M 73.98M 73.60M 76.57M 0.00 72.30M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
62.51M 64.02M 66.94M 74.20M 73.78M 73.41M 0.00 83.92M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-188 184 352 -41 -424 405 483 126 -64 48
Normalized NOPAT Margin
-1.59% 1.12% 1.78% -0.38% -5.81% 4.35% 4.72% 1.74% -1.53% 1.01%
Pre Tax Income Margin
-5.96% 0.10% 1.63% -1.29% -10.51% 4.33% 4.74% 4.12% -9.32% 0.45%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 -0.14 -5.35 3.72 4.48 4.01 -0.91 1.35
NOPAT to Interest Expense
0.00 0.00 0.00 -0.18 -4.08 3.09 3.58 2.11 -0.63 2.30
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 -1.68 -7.49 0.70 2.59 2.18 -1.76 -2.23
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 -1.72 -6.22 0.06 1.69 0.28 -1.48 -1.28
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
-12.32% 129.12% 27.13% 0.00% -17.08% 25.82% 21.37% 26.97% -46.18% 132.72%
Augmented Payout Ratio
-20.29% 311.99% 93.77% 0.00% -17.41% 78.79% 118.81% 34.72% -50.67% 229.29%

Quarterly Metrics And Ratios for Delek US

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-15.54% -41.90% -34.27% -18.45% -17.75% -7.83% -13.07% -29.87% -11.99% 29.81% 80.11%
EBITDA Growth
-118.85% -308.84% -110.43% -24.03% -44.88% -9.39% 131.04% -75.39% 105.19% -174.95% 5.06%
EBIT Growth
-516.78% -154.78% -157.78% -72.78% -77.72% -18.44% 291.25% -90.02% 230.18% -648.79% -10.05%
NOPAT Growth
-530.82% -159.39% -149.55% -73.05% -80.46% -18.30% 302.27% -90.95% 203.43% -642.00% 37.62%
Net Income Growth
-528.97% -151.16% -149.60% -1,640.00% -134.90% -45.94% 710.12% -100.41% 387.84% -2,050.98% -18.45%
EPS Growth
-445.10% -160.24% -160.91% -346.15% -153.68% -50.91% 1,870.00% -102.57% 955.56% -870.59% -37.50%
Operating Cash Flow Growth
-137.43% -280.07% -104.99% -150.89% -57.81% 131.22% 232.26% -82.99% 1,374.25% -280.40% 72.91%
Free Cash Flow Firm Growth
-142.38% -153.25% -2.65% 405.80% 151.04% 166.64% 134.26% 41.00% -295.04% -419.50% -160.94%
Invested Capital Growth
1.49% 2.73% -9.26% -10.74% -10.14% -26.32% 0.80% 5.19% 34.98% 43.85% 24.19%
Revenue Q/Q Growth
22.28% -28.99% -11.09% 6.01% -20.29% -19.67% 10.33% 6.91% -12.39% -24.24% -10.99%
EBITDA Q/Q Growth
92.72% -930.82% -128.88% -17.88% 351.66% -126.29% 110.43% -40.42% 990.46% -155.53% -77.59%
EBIT Q/Q Growth
69.76% -238.30% -999.26% -59.58% 124.10% -176.73% 323.59% -66.91% 244.13% -353.45% -89.19%
NOPAT Q/Q Growth
69.75% -241.10% -1,002.96% -58.72% 123.75% -165.16% 391.03% -70.07% 261.71% -321.57% -88.96%
Net Income Q/Q Growth
60.58% -495.70% -158.62% -3.57% 84.26% -217.63% 9,173.33% -102.08% 165.82% -752.98% -95.44%
EPS Q/Q Growth
57.10% -440.00% -106.90% -13.73% 79.52% -226.40% 1,615.38% -113.68% 157.58% -1,750.00% -98.02%
Operating Cash Flow Q/Q Growth
61.83% -656.94% 55.37% -129.03% 83.59% -79.01% 354.89% -75.93% 235.87% -323.35% -76.71%
Free Cash Flow Firm Q/Q Growth
64.59% -335.89% -50.29% 1.21% -34.40% 331.24% 256.16% 83.11% 40.06% -121.70% -168.96%
Invested Capital Q/Q Growth
10.50% -3.35% -4.63% -0.36% 1.33% -14.63% -6.19% 0.31% -8.28% 16.79% -2.10%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-2.41% -9.70% -0.66% 1.65% 4.03% -3.34% 6.01% 3.76% 6.04% -3.46% 2.65%
EBITDA Margin
-0.87% -14.55% -1.00% 3.09% 3.98% -2.07% 6.32% 3.31% 5.95% -1.74% 2.38%
Operating Margin
-4.76% -19.25% -4.01% 0.39% 1.01% -4.31% 4.58% 1.19% 3.64% -3.36% 1.00%
EBIT Margin
-4.70% -19.01% -3.99% 0.39% 1.03% -4.34% 4.54% 1.18% 3.82% -3.37% 1.01%
Profit (Net Income) Margin
-6.00% -18.61% -2.22% -0.76% -0.78% -4.31% 2.94% -0.04% 1.84% -2.72% 0.32%
Tax Burden Percent
81.28% 86.53% 38.55% 77.22% 77.78% 72.51% 87.98% 28.30% 82.05% 59.01% 80.77%
Interest Burden Percent
157.00% 113.15% 144.23% -250.37% -97.01% 136.97% 73.63% -10.69% 58.71% 136.59% 38.73%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.81% 0.00% 17.95% 0.00% 19.23%
Return on Invested Capital (ROIC)
-15.62% -73.16% -16.16% 1.68% 4.52% -19.58% 25.51% 5.71% 25.23% -18.80% 6.72%
ROIC Less NNEP Spread (ROIC-NNEP)
-19.77% -81.01% -14.85% -0.66% 1.24% -22.73% 22.72% 3.14% 21.72% -19.83% 4.41%
Return on Net Nonoperating Assets (RNNOA)
-45.74% -149.37% -19.12% -0.98% 1.68% -34.12% 24.06% 3.72% 26.56% -27.32% 4.41%
Return on Equity (ROE)
-61.36% -222.52% -35.28% 0.70% 6.20% -53.70% 49.58% 9.44% 51.79% -46.11% 11.12%
Cash Return on Invested Capital (CROIC)
-20.13% -18.45% 3.87% 15.02% 15.35% 41.69% 11.57% -1.26% -9.20% -20.73% 0.06%
Operating Return on Assets (OROA)
-7.60% -32.56% -7.42% 0.83% 2.24% -9.29% 9.61% 2.54% 9.57% -8.90% 2.51%
Return on Assets (ROA)
-9.70% -31.88% -4.13% -1.60% -1.69% -9.23% 6.23% -0.08% 4.61% -7.18% 0.79%
Return on Common Equity (ROCE)
-42.34% -167.93% -29.22% 0.59% 5.33% -47.34% 44.66% 8.48% 45.65% -40.67% 9.93%
Return on Equity Simple (ROE_SIMPLE)
-420.98% 0.00% -39.67% -9.34% -5.93% 0.00% 9.36% -2.36% 34.79% 0.00% 34.05%
Net Operating Profit after Tax (NOPAT)
-88 -291 -85 9.45 23 -112 172 35 117 -95 43
NOPAT Margin
-3.33% -13.47% -2.80% 0.28% 0.71% -3.02% 3.72% 0.84% 2.99% -2.35% 0.80%
Net Nonoperating Expense Percent (NNEP)
4.16% 7.85% -1.32% 2.34% 3.28% 3.14% 2.79% 2.57% 3.50% 1.03% 2.31%
Return On Investment Capital (ROIC_SIMPLE)
-2.54% -8.71% - - - -3.15% - - - -2.30% -
Cost of Revenue to Revenue
102.41% 109.70% 100.66% 98.35% 95.97% 103.34% 93.99% 96.24% 93.96% 103.46% 97.35%
SG&A Expenses to Revenue
2.33% 2.54% 2.31% 1.84% 2.00% 1.53% 1.46% 1.81% 1.82% 2.03% 1.11%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
2.35% 9.55% 3.34% 1.26% 3.02% 0.97% 1.42% 2.56% 2.40% -0.10% 1.65%
Earnings before Interest and Taxes (EBIT)
-124 -411 -121 14 33 -161 210 50 150 -136 54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 -314 -31 106 129 -77 293 139 233 -70 127
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.06 3.74 1.72 1.95 2.25 1.86 1.70 1.59 1.45 1.84 1.54
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.65
Price to Revenue (P/Rev)
0.08 0.10 0.09 0.10 0.12 0.10 0.10 0.08 0.07 0.09 0.09
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 79.62 26.78 0.00 4.60 6.74 4.93
Dividend Yield
6.74% 5.43% 5.28% 3.97% 3.89% 3.75% 4.02% 4.65% 3.84% 2.45% 1.59%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 1.26% 3.73% 0.00% 21.76% 14.84% 20.26%
Enterprise Value to Invested Capital (EV/IC)
1.32 1.39 1.22 1.32 1.44 1.44 1.29 1.21 1.17 1.27 1.25
Enterprise Value to Revenue (EV/Rev)
0.28 0.26 0.20 0.20 0.21 0.19 0.19 0.18 0.16 0.19 0.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 16.04 6.36 6.55 5.29 5.09 6.87 3.48 5.05 3.48
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 24.10 20.78 12.51 10.64 21.75 5.24 8.07 5.04
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 33.91 29.25 10.76 10.47 32.56 6.52 9.83 6.40
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 14.91 4.93 4.43 3.07 5.15 9.85 3.94 8.73 3.57
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 30.05 8.28 8.90 2.94 11.19 0.00 0.00 0.00 2,345.50
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
7.07 4.81 2.95 2.50 2.41 2.71 2.28 2.64 2.47 2.86 2.13
Long-Term Debt to Equity
7.05 4.79 2.94 2.50 2.40 2.66 2.25 2.60 2.42 2.79 2.08
Financial Leverage
2.31 1.84 1.29 1.49 1.36 1.50 1.06 1.18 1.22 1.38 1.00
Leverage Ratio
9.60 9.02 7.09 7.19 6.93 7.57 6.67 6.96 7.50 7.20 6.71
Compound Leverage Factor
15.08 10.20 10.22 -18.01 -6.72 10.37 4.91 -0.74 4.40 9.84 2.60
Debt to Total Capital
87.61% 82.78% 74.69% 71.47% 70.69% 73.04% 69.51% 72.56% 71.17% 74.06% 68.06%
Short-Term Debt to Total Capital
0.27% 0.28% 0.25% 0.28% 0.41% 1.25% 0.78% 1.28% 1.27% 1.81% 1.57%
Long-Term Debt to Total Capital
87.33% 82.50% 74.43% 71.19% 70.28% 71.79% 68.74% 71.28% 69.90% 72.25% 66.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
7.91% 7.86% 6.49% 5.14% 5.09% 3.21% 3.14% 3.14% 3.19% 3.05% 3.05%
Common Equity to Total Capital
4.49% 9.36% 18.83% 23.39% 24.21% 23.75% 27.34% 24.30% 25.65% 22.89% 28.89%
Debt to EBITDA
-11.90 -24.98 16.00 4.95 4.70 4.42 4.13 5.95 3.09 4.16 3.04
Net Debt to EBITDA
-7.90 -14.79 7.71 2.85 2.59 2.41 2.14 3.44 1.73 2.52 1.36
Long-Term Debt to EBITDA
-11.86 -24.89 15.95 4.93 4.68 4.35 4.08 5.84 3.03 4.05 2.97
Debt to NOPAT
-6.71 -8.04 -19.84 26.40 21.01 9.00 8.50 28.20 5.78 8.09 5.59
Net Debt to NOPAT
-4.45 -4.76 -9.56 15.20 11.55 4.91 4.40 16.31 3.24 4.91 2.49
Long-Term Debt to NOPAT
-6.69 -8.01 -19.78 26.30 20.89 8.84 8.40 27.70 5.68 7.90 5.46
Altman Z-Score
1.53 1.61 2.10 2.44 2.55 2.45 2.60 2.60 2.87 2.69 2.57
Noncontrolling Interest Sharing Ratio
30.99% 24.54% 17.20% 14.60% 14.09% 11.83% 9.92% 10.17% 11.85% 11.79% 10.69%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.85 0.93 1.04 0.98 1.04 0.99 1.11 1.10 1.11 1.20 1.05
Quick Ratio
0.49 0.54 0.65 0.56 0.61 0.60 0.69 0.63 0.60 0.67 0.57
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-124 -350 148 298 295 657 152 -98 -577 -986 -445
Operating Cash Flow to CapEx
-47.49% -85.65% -21.01% -56.28% 352.43% 126.82% 1,027.55% 143.44% 186.99% -328.96% 137.63%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 3.84 3.36 0.00 0.00 -1.21 -7.55 0.00 -8.77
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 -0.62 1.90 0.00 0.00 1.18 5.16 0.00 2.57
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 -1.73 1.36 0.00 0.00 0.36 2.40 0.00 0.70
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.62 1.71 1.86 2.10 2.17 2.14 2.12 2.15 2.51 2.64 2.49
Accounts Receivable Turnover
15.35 16.92 16.04 17.41 19.32 16.32 15.64 15.43 17.50 19.69 18.47
Inventory Turnover
12.24 12.97 13.04 13.07 13.28 12.94 11.75 11.27 12.70 13.71 13.14
Fixed Asset Turnover
3.79 4.21 4.89 5.46 5.71 6.02 6.25 6.48 7.65 7.79 7.56
Accounts Payable Turnover
6.49 6.56 7.34 7.76 8.86 8.94 7.95 7.82 8.60 11.07 9.35
Days Sales Outstanding (DSO)
23.77 21.58 22.76 20.97 18.90 22.37 23.33 23.65 20.86 18.53 19.76
Days Inventory Outstanding (DIO)
29.82 28.14 27.99 27.93 27.49 28.20 31.05 32.39 28.73 26.62 27.77
Days Payable Outstanding (DPO)
56.26 55.66 49.72 47.04 41.21 40.81 45.88 46.65 42.45 32.96 39.04
Cash Conversion Cycle (CCC)
-2.67 -5.94 1.02 1.86 5.18 9.75 8.50 9.39 7.14 12.20 8.48
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,444 2,212 2,289 2,400 2,408 2,153 2,522 2,689 2,680 2,922 2,502
Invested Capital Turnover
4.68 5.43 5.76 6.07 6.38 6.49 6.86 6.84 8.45 7.99 8.36
Increase / (Decrease) in Invested Capital
36 59 -234 -289 -272 -769 20 133 695 891 487
Enterprise Value (EV)
3,231 3,068 2,795 3,162 3,477 3,108 3,252 3,245 3,127 3,711 3,130
Market Capitalization
942 1,169 1,210 1,568 1,924 1,577 1,767 1,498 1,447 1,732 1,788
Book Value per Share
$2.49 $4.95 $10.89 $12.56 $13.36 $13.22 $16.01 $14.32 $14.94 $13.54 $16.33
Tangible Book Value per Share
($11.56) ($7.66) ($4.85) ($3.24) ($2.58) ($2.03) ($0.11) ($1.64) ($0.82) ($1.67) $1.35
Total Capital
3,465 3,340 3,735 3,445 3,532 3,560 3,795 3,874 3,899 4,123 4,017
Total Debt
3,035 2,765 2,789 2,462 2,497 2,600 2,638 2,811 2,775 3,054 2,734
Total Long-Term Debt
3,026 2,756 2,780 2,452 2,482 2,555 2,609 2,761 2,726 2,979 2,671
Net Debt
2,015 1,637 1,343 1,417 1,373 1,417 1,365 1,626 1,556 1,853 1,219
Capital Expenditures (CapEx)
131 191 103 86 47 72 42 66 211 88 95
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-991 -910 -930 -712 -637 -796 -542 -491 -499 -136 -891
Debt-free Net Working Capital (DFNWC)
-368 -175 107 -54 116 25 360 331 367 705 263
Net Working Capital (NWC)
-377 -184 98 -64 102 -19 331 282 317 631 200
Net Nonoperating Expense (NNE)
70 111 -18 36 48 48 36 37 45 15 26
Net Nonoperating Obligations (NNO)
2,015 1,637 1,343 1,417 1,373 1,194 1,365 1,626 1,556 1,853 1,219
Total Depreciation and Amortization (D&A)
101 96 91 92 95 84 82 89 83 66 73
Debt-free, Cash-free Net Working Capital to Revenue
-8.72% -7.68% -6.71% -4.61% -3.93% -4.84% -3.14% -2.74% -2.53% -0.69% -4.72%
Debt-free Net Working Capital to Revenue
-3.23% -1.47% 0.77% -0.35% 0.72% 0.15% 2.09% 1.85% 1.86% 3.56% 1.39%
Net Working Capital to Revenue
-3.32% -1.55% 0.71% -0.41% 0.63% -0.12% 1.92% 1.57% 1.61% 3.18% 1.06%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.78) ($6.48) ($1.20) ($0.58) ($0.51) ($2.51) $1.98 ($0.13) $0.96 ($1.68) $0.11
Adjusted Weighted Average Basic Shares Outstanding
62.12M 63.88M 64.06M 64.21M 64.02M 65.41M 64.89M 65.77M 66.95M 70.79M 69.69M
Adjusted Diluted Earnings per Share
($2.78) ($6.48) ($1.20) ($0.58) ($0.51) ($2.49) $1.97 ($0.13) $0.95 ($1.65) $0.10
Adjusted Weighted Average Diluted Shares Outstanding
62.12M 63.88M 64.06M 64.21M 64.02M 65.41M 65.46M 65.77M 67.37M 71.52M 69.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
60.73M 62.51M 63.20M 64.54M 64.13M 64.02M 63.93M 64.82M 65.73M 66.94M 69.69M
Normalized Net Operating Profit after Tax (NOPAT)
-88 -291 -79 25 23 -112 172 35 117 -95 43
Normalized NOPAT Margin
-3.33% -13.47% -2.59% 0.73% 0.71% -3.02% 3.72% 0.84% 2.99% -2.35% 0.80%
Pre Tax Income Margin
-7.38% -21.51% -5.76% -0.99% -1.00% -5.94% 3.34% -0.13% 2.24% -4.61% 0.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.17 0.38 0.00 0.00 0.62 1.96 0.00 1.06
NOPAT to Interest Expense
0.00 0.00 0.00 0.12 0.26 0.00 0.00 0.44 1.53 0.00 0.84
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 -0.93 -0.16 0.00 0.00 -0.21 -0.80 0.00 -0.81
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 -0.99 -0.28 0.00 0.00 -0.39 -1.23 0.00 -1.02
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-9.84% -12.32% -22.77% -57.37% -121.50% 129.12% 98.25% -574.77% 27.11% 27.13% 7.16%
Augmented Payout Ratio
-21.00% -20.29% -37.11% -117.13% -289.15% 311.99% 257.88% -1,340.54% 64.47% 93.77% 33.49%

Frequently Asked Questions About Delek US's Financials

When does Delek US's financial year end?

According to the most recent income statement we have on file, Delek US's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Delek US's net income changed over the last 9 years?

Delek US's net income appears to be on a downward trend, with a most recent value of -$520.90 million in 2024, falling from $43.70 million in 2015. The previous period was $46.70 million in 2023. Check out Delek US's forecast to explore projected trends and price targets.

What is Delek US's operating income?
Delek US's total operating income in 2024 was -$491.50 million, based on the following breakdown:
  • Total Gross Profit: -$43.10 million
  • Total Operating Expenses: $448.40 million
How has Delek US revenue changed over the last 9 years?

Over the last 9 years, Delek US's total revenue changed from $4.78 billion in 2015 to $11.85 billion in 2024, a change of 147.9%.

How much debt does Delek US have?

Delek US's total liabilities were at $6.09 billion at the end of 2024, a 2.0% decrease from 2023, and a 238.9% increase since 2016.

How much cash does Delek US have?

In the past 8 years, Delek US's cash and equivalents has ranged from $689.20 million in 2016 to $1.08 billion in 2018, and is currently $735.60 million as of their latest financial filing in 2024.

How has Delek US's book value per share changed over the last 9 years?

Over the last 9 years, Delek US's book value per share changed from 0.00 in 2015 to 4.95 in 2024, a change of 495.0%.



This page (NYSE:DK) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners